Cargando…

Author Correction: Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice

Detalles Bibliográficos
Autores principales:	Rossin, Raffaella, Versteegen, Ron M., Wu, Jeremy, Khasanov, Alisher, Wessels, Hans J., Steenbergen, Erik J., ten Hoeve, Wolter, Janssen, Henk M., van Onzen, Arthur H. A. M., Hudson, Peter J., Robillard, Marc S.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Nature Publishing Group UK 2019
Materias:	Author Correction
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6335410/ https://www.ncbi.nlm.nih.gov/pubmed/30651544 http://dx.doi.org/10.1038/s41467-019-08376-x

Ejemplares similares

Chemically triggered drug release from an antibody-drug conjugate leads to potent antitumour activity in mice
por: Rossin, Raffaella, et al.
Publicado: (2018)

Antitumour Drug-Radiation Interactions
por: Carmichael, J.
Publicado: (1992)

Tin-based Antitumour Drugs
por: Gielen, Marcel
Publicado: (1994)

MDR1 causes resistance to the antitumour drug miltefosine
por: Rybczynska, M, et al.
Publicado: (2001)

Tetrazine—trans-Cyclooctene Chemistry Applied to Fabricate Self-Assembled Fluorescent and Radioactive Nanoparticles for in Vivo Dual Mode Imaging
por: van Onzen, Arthur H. A. M., et al.
Publicado: (2019)

Tin-Based Antitumour Drugs: New Developments
por: Gielen, Marcel
Publicado: (1995)

Effect of liposomally trapped antitumour drugs on a drug-resistant mouse lymphoma in vivo
por: Richardson, V. J., et al.
Publicado: (1982)

Enhancement of antitumour activity of etoposide by dihydropyridines on drug-sensitive and drug-resistant leukaemia in mice.
por: Kiue, A., et al.
Publicado: (1991)

Modulation of the toxicity and antitumour activity of alkylating drugs by steroids.
por: Shepherd, R., et al.
Publicado: (1982)

SPARC independent drug delivery and antitumour effects of nab-paclitaxel in genetically engineered mice
por: Neesse, Albrecht, et al.
Publicado: (2014)

Discovery of secondary sulphonamides as IDO1 inhibitors with potent antitumour effects in vivo
por: Ge, Shushan, et al.
Publicado: (2020)

Furan-Conjugated Tripeptides as Potent Antitumor Drugs
por: Ali, Hunain, et al.
Publicado: (2020)

Antitumour activity of peroxidases.
por: Everse, K. E., et al.
Publicado: (1985)

Molecular basis for Poria cocos mushroom polysaccharide used as an antitumour drug in China
por: Li, Xiulian, et al.
Publicado: (2018)

The antitumour activities of statins
por: Takahashi, H.K., et al.
Publicado: (2007)

Combination of the anti-CD30-auristatin-E antibody-drug conjugate (SGN-35) with chemotherapy improves antitumour activity in Hodgkin lymphoma
por: Oflazoglu, Ezogelin, et al.
Publicado: (2008)

Antitumour Antibiotics
por: Fox, B. W.
Publicado: (1979)

The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
por: Evans, Jonathan P., et al.
Publicado: (2018)

NIR-driven Smart Theranostic Nanomedicine for On-demand Drug Release and Synergistic Antitumour Therapy
por: Zhao, Pengfei, et al.
Publicado: (2015)

Alpha-alumina nanoparticles induce efficient autophagy-dependent cross-presentation and potent antitumour response
por: Li, Haiyan, et al.
Publicado: (2011)

Correction: The Nrf2 inhibitor brusatol is a potent antitumour agent in an orthotopic mouse model of colorectal cancer
por: Evans, Jonathan P., et al.
Publicado: (2019)

CAR exosomes derived from effector CAR-T cells have potent antitumour effects and low toxicity
por: Fu, Wenyan, et al.
Publicado: (2019)

Preclinical emergence of vandetanib as a potent antitumour agent in mesothelioma: molecular mechanisms underlying its synergistic interaction with pemetrexed and carboplatin
por: Giovannetti, E, et al.
Publicado: (2011)

Targeted antitumour therapy – future perspectives
por: Ranson, M, et al.
Publicado: (2005)

Non-viral immune electrogene therapy induces potent antitumour responses and has a curative effect in murine colon adenocarcinoma and melanoma cancer models
por: Forde, P F, et al.
Publicado: (2015)

Antitumour imidazotetrazines, Part IX. The pharmacokinetics of mitozolomide in mice.
por: Goddard, C., et al.
Publicado: (1985)

Se-methylselenocysteine offers selective protection against toxicity and potentiates the antitumour activity of anticancer drugs in preclinical animal models
por: Cao, S, et al.
Publicado: (2014)

The antitumour drug ABTL0812 impairs neuroblastoma growth through endoplasmic reticulum stress-mediated autophagy and apoptosis
por: París-Coderch, Laia, et al.
Publicado: (2020)

Apatinib inhibits tumour progression and promotes antitumour efficacy of cytotoxic drugs in oesophageal squamous cell carcinoma
por: Chi, Yanyan, et al.
Publicado: (2022)

Dectin-1-activated dendritic cells trigger potent antitumour immunity through the induction of Th9 cells
por: Zhao, Yinghua, et al.
Publicado: (2016)

Potent antitumour activity of interleukin-2-Fc fusion proteins requires Fc-mediated depletion of regulatory T-cells
por: Vazquez-Lombardi, Rodrigo, et al.
Publicado: (2017)

CAR T cells expressing a bacterial virulence factor trigger potent bystander antitumour responses in solid cancers
por: Jin, Chuan, et al.
Publicado: (2022)

Microcolin H, a novel autophagy inducer, exerts potent antitumour activity by targeting PITPα/β
por: Yang, Hange, et al.
Publicado: (2023)

The realisation of targeted antitumour therapy
por: Bicknell, R
Publicado: (2005)

An Overview of Antitumour Activity of Polysaccharides
por: Jin, Hongzhen, et al.
Publicado: (2022)

Inhibition of all-TRANS-retinoic acid metabolism by R116010 induces antitumour activity
por: Van heusden, J, et al.
Publicado: (2002)

Antitumour Activity of a pt(III) Derivative of 2-Mercaptopyrimidine
por: Cervantes, G., et al.
Publicado: (1997)

Pooled peptides from HER-2/neu-overexpressing primary ovarian tumours induce CTL with potent antitumour responses in vitro and in vivo
por: Gritzapis, A D, et al.
Publicado: (2005)

The Soviet doctor and the treatment of drug addiction: "A difficult and most ungracious task"
por: Latypov, Alisher B
Publicado: (2011)

MDM2 antagonist Nutlin-3a potentiates antitumour activity of cytotoxic drugs in sarcoma cell lines
por: Ohnstad, Hege O, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_5athnfef2o2g1psd4gj4hbidpg